Clinical trials
Phase 3 Cardiovascular Diseases trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| GlaxoSmithKline | 2 |
| Sanofi | 2 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| CSL Behring | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 14 |
| Myocardial Infarction | 5 |
| Stroke | 5 |
| Acute Coronary Syndrome | 3 |
| Atherosclerosis | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Diseases | 3 |
| Atrial Fibrillation | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.